Company Filing History:
Years Active: 2021
Title: Tanja Poljak: Innovator in Medicinal Chemistry
Introduction
Tanja Poljak is a prominent inventor based in Zagreb, Croatia. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative research and development of pharmaceutical compounds. With a total of two patents to her name, her work focuses on addressing critical health issues.
Latest Patents
Tanja Poljak's latest patents include the development of pyrrolopyrimidine and pyrrolopyridine derivatives. These compounds are designed for the prophylaxis and treatment of various conditions such as pain, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, and cancer. Specifically, these compounds act as ASK inhibitors, particularly targeting ASK1. Additionally, she has developed modulators of the hedgehog (Hh) signaling pathway, which are intended for use as medicaments in treating conditions related to abnormal activation of this pathway, including cancer and chronic graft-versus-host disease.
Career Highlights
Throughout her career, Tanja has worked with notable companies such as Galapagos NV and E-Therapeutics Plc. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative therapeutic solutions.
Collaborations
Tanja Poljak has collaborated with esteemed colleagues, including Dinko Ziher and David Amantini. These partnerships have further enriched her research endeavors and expanded the impact of her work in the field.
Conclusion
Tanja Poljak is a remarkable inventor whose contributions to medicinal chemistry are paving the way for new treatments for various diseases. Her innovative patents and collaborations highlight her commitment to improving healthcare through scientific advancements.